PLoS ONE (Jan 2020)

Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey.

  • Daphne C Wu,
  • Prabhat Jha,
  • Teresa Lam,
  • Patrick Brown,
  • Hellen Gelband,
  • Nico Nagelkerke,
  • H Chaim Birnboim,
  • Angus Reid,
  • Action to Beat Coronavirus in Canada/Action pour Battre le Coronavirus (Ab-C) Study Group

DOI
https://doi.org/10.1371/journal.pone.0240778
Journal volume & issue
Vol. 15, no. 10
p. e0240778

Abstract

Read online

Random population-based surveys to estimate prevalence of SARS-CoV2 infection causing coronavirus disease (COVID-19) are useful to understand distributions and predictors of the infection. In April 2020, the first-ever nationally representative survey in Canada polled 4,240 adults age 18 years and older about self-reported COVID experience in March, early in the epidemic. We examined the levels and predictors of COVID symptoms, defined as fever plus difficulty breathing/shortness of breath, dry cough so severe that it disrupts sleep, and/or loss of sense of smell; and testing for SARS-CoV-2 by respondents and/or household members. About 8% of Canadians reported that they and/or one or more household members experienced COVID symptoms. Symptoms were more common in younger than in older adults, and among visible minorities. Overall, only 3% of respondents and/or household members reported testing for SARS-CoV-2. Being tested was associated with having COVID symptoms, Indigenous identity, and living in Quebec. Periodic nationally representative surveys of symptoms, as well as SARS-CoV-2 antibodies, are required in many countries to understand the pandemic and prepare for the future.